Magnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of Cancer
Open Access
- 30 July 2013
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (8), 15910-15930
- https://doi.org/10.3390/ijms140815910
Abstract
Superparamagnetic iron oxide nanoparticles (SPION) have emerged as an MRI contrast agent for tumor imaging due to their efficacy and safety. Their utility has been proven in clinical applications with a series of marketed SPION-based contrast agents. Extensive research has been performed to study various strategies that could improve SPION by tailoring the surface chemistry and by applying additional therapeutic functionality. Research into the dual-modal contrast uses of SPION has developed because these applications can save time and effort by reducing the number of imaging sessions. In addition to multimodal strategies, efforts have been made to develop multifunctional nanoparticles that carry both diagnostic and therapeutic cargos specifically for cancer. This review provides an overview of recent advances in multimodality imaging agents and focuses on iron oxide based nanoparticles and their theranostic applications for cancer. Furthermore, we discuss the physiochemical properties and compare different synthesis methods of SPION for the development of multimodal contrast agents.Keywords
This publication has 70 references indexed in Scilit:
- HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer TherapyMolecular Pharmaceutics, 2011
- Synthesis of 64CuII–Bis(dithiocarbamatebisphosphonate) and Its Conjugation with Superparamagnetic Iron Oxide Nanoparticles: In Vivo Evaluation as Dual‐Modality PET–MRI AgentAngewandte Chemie-International Edition, 2011
- cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imagingBiomaterials, 2011
- Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challengesTrends in Molecular Medicine, 2010
- PET/NIRF/MRI triple functional iron oxide nanoparticlesBiomaterials, 2010
- Multimodality Imaging: Beyond PET/CT and SPECT/CTSeminars in Nuclear Medicine, 2009
- Drug/Dye‐Loaded, Multifunctional Iron Oxide Nanoparticles for Combined Targeted Cancer Therapy and Dual Optical/Magnetic Resonance ImagingSmall, 2009
- Optical contrast agents and imaging systems for detection and diagnosis of cancerInternational Journal of Cancer, 2008
- Superparamagnetic Iron Oxide Nanoparticles Coated with Galactose-Carrying Polymer for Hepatocyte TargetingJournal of Biomedicine and Biotechnology, 2007
- Molecular imaging perspectivesJournal of The Royal Society Interface, 2005